SUN GLOBAL
SUN GLOBAL
Factory direct peptide supply
GHRH Analog (DAC)
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) with a Drug Affinity Complex (DAC) that extends its half-life significantly. By binding to albumin in the bloodstream, it achieves a half-life of 6-8 days compared to minutes for native GHRH. It is commonly used in research for its ability to increase GH and IGF-1 levels in a pulsatile, physiological manner.
For faster quotation, include purity, quantity, packaging request and target market.
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH) with a Drug Affinity Complex (DAC) that extends its half-life significantly. By binding to albumin in the bloodstream, it achieves a half-life of 6-8 days compared to minutes for native GHRH. It is commonly used in research for its ability to increase GH and IGF-1 levels in a pulsatile, physiological manner.
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser-Asn-Gln-Glu-Arg-Gly-Ala-Arg-Ala-Arg-Leu-NH₂
Batch-specific testing results
Factory supply workflow
Send the product name, selected strength, quantity, purity requirement, packaging style and destination market. The sales team can confirm stock, MOQ, batch COA, HPLC/MS files, lead time and private label options.
Product name, mg/vial, vial count and target quantity.
Batch COA, HPLC, MS, appearance and storage conditions.
Factory price, MOQ, label, box and custom brand support.
Fast preparation with export support and shipment updates.
Peer-reviewed scientific literature on CJC-1295 from PubMed, NEJM, The Lancet, and other authoritative sources.
Teichman SL, Neale A, Lawrence B, et al.
Journal of Clinical Endocrinology & Metabolism, 91: 799–805 (2006)
CJC-1295 produced dose-dependent increases in mean GH concentrations (2- to 10-fold) and IGF-1 levels (1.5- to 3-fold) that were sustained for 6–8 days after a single injection, demonstrating its extended pharmacodynamic profile.
Walker RF.
Rejuvenation Research, 9: 200–205 (2006)
The combination of a GHRH analog with a GHRP produces synergistic GH release exceeding either compound alone, with the GHRH component amplifying GH pulse amplitude and the GHRP component increasing pulse frequency.
